Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have been looking at NAT to make an initial purchase. I agree with you. Although I think it would be OK to buy in here, I am waiting until all of tax loss selling, if any, is finished. I also believe an overall market correction is coming. That should provide about the best entry point possible, and just before, what I expect will be a dividend announcement, later in Jan.
Be patient with your buy, I think were heading back to 4.00 or less again. Pick some up then. I still have a buy set at 3.80. Like I said back when I set the buy, I figure it will hang out around 4.00 and I want to be ready for one of those intraday drops that recovers back to 4.00. I also have a number at which I will sell some.
Thinking the exact same thing!
I still have my 2 buy orders in that I mentioned in a previous post. With the futures cratering last night I thought there might be a short term drop that would trigger the orders but things recovered before the market opened and then turned positive as the day went on. I was hoping to catch a big dip and then have good earnings news after the buy kicked in. No such luck. But, with the earnings report not looking good, I am expecting share price to drop. If it does, I'll be adding.
I don't think the after hours jump will hold tomorrow morning. I'm not seeing great news in this earnings report.
An excerpt from an article for a different stock.
Stocks to Consider
Here are some companies to consider as our model shows that they have the right combination of elements to post an earnings beat this quarter:
AveXis, Inc. AVXS is scheduled to release results on Nov 10. The company has an Earnings ESP of 11.43% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Global Blood Therapeutics, Inc. GBT with an Earnings ESP of +16.95% and a Zacks Rank #2. The company is expected to release results on Nov 10.
Ekso Bionics Holdings, Inc. EKSO with an Earnings ESP of +9.76% and a Zacks Rank #3. The company is scheduled to release results on Nov 9.
Hope they are right.
It is just my opinion, I am thinking that the pps will be in the same range it was from mid-August through September as we head into the earnings release. After that it's anyone's guess, a good report and we're back to above $6. My next buy is 3.80 and then again at 3.60. If pps drops much below that, we may be in trouble.
Just filled my second buy back so I now have 1/2 my shares back...don't like the decline but I have no choice but to take advantage of it, temporarily.
Next buy is at 4.00...I am thinking we will re-test lows so that is what I based my buys on
Not trading by choice...used the trailing stop to protect from huge loss. I got burned not using them in the past. Just trying to get back in
Just picked up 1/4 of the shares that were sold out with the trailing stop. They stopped out at 4.75, I just picked some up at 4.20. I have 3 more buys set in stages if the pps should fall to the other support levels. If this works out I will end up with more shares at a much lower average/share. Should have done this at 6.00 when I first thought about doing it.
Actually, I think next support is more like 4.00 (not 3.60-3.75 as I stated), then the next is 3.50
Now I have to wait and try to find a good re-entry point. Thinking somewhere between 3.60 and 3.75, that looks to be the next support level. Sometimes trailing stops can work against you. Kicked me out at 4.75
I have a buy order in, hoping to take advantage of those (pre and after market)huge dips; that we have been seeing, which are followed by a recovery.
http://www.nasdaq.com/press-release/researchers-to-present-latest-clinical-evidence-for-ekso-gt-robotic-exoskeleton-at-acrm-93rd-annua-20161026-00137
I don't think this article or anything from the presentations will have any effect on the share price.
If investors had the traditional 25% trailing stops, they are kicking in and selling off shares. I am out.
I was debating the same thing and haven't pulled the trigger on a sell for the same reason.
I attach a link to the complete article....a possible explanation as to why the article has some merit...not the Gottbetter part but read the part about the expiration of lock-up.
http://www.thestreetsweeper.org/
http://cnafinance.com/ekso-bionics-ekso-stock-heres-why-its-tanking/11562
I don't know how reliable any of this is.
Seems like this is based on old info and short attack BS
On average, analysts expect that Ekso Bionics Holdings will post ($1.74) EPS for the current year.
http://www.dailypolitical.com/2016/10/13/ekso-bionics-holdings-inc-ekso-now-covered-by-suntrust-banks-inc.html
Yeah, it followed the NASDAQ pattern, just a bit more to extremes. Let see if we can finish the week here.
Actually, earlier today, I was wondering how ReWalk's stock was doing and how they compared.
Sounds good to me.
Wow, this is a rare sight, EKSO is the only green in my portfolio!
If you look at the 52 week chart, we are beginning to reach resistance level. I am expecting us to hold around this level for a while. Next level would be around 6.30 We are also in the overbought zone. Hopefully only a pause, then push higher.
Question: What is the likelihood of another stock offering in the near future, with the stabilizing of the share price? We are back to about where we were when they announced the issuance in Aug.
I am pretty sure they are still going to need to raise money again.
This price run up looks a lot like the run back then, there was actually no (financial or sales)news then either, but it kept moving higher.
This may explain some of Ekso's recent moves. If previous Cyberdyne Investors are seeking to re-invest money they have taken out, but still believe in the technology.
My second point here as that Citron Research has been involved in the downfall of several stocks. They claim that they research a company and then take a short position. To me that is fine, but the problem I have is that they produce negative articles upon negative article about the company, driving the price lower. EKSO needs to be careful about the accuracy of the clinical trials and the claims it makes concerning their devices. Once Citron latches on you can bet on a crash in share price. Once someone starts the negative news it is hard to defend yourself even if the news is incorrect. I suggest people keep their eye on Citron here.
http://www.valuewalk.com/2016/10/citron-research-cyberdyne/
I agree, a good sales announcement would be great. I'm not a fan of volatility, I am not a trader. If I knew how to take advantage of the swings I would feel differently. I would rather have consistent, sustained small moves higher. Just keep marching higher.
Here is a portion of the article posted the other day that included a video of Mr. Oldt walking with the GT...so I don't think that today's release is actually that new after all... I believe it was also mentioned in previous videos.
The physical therapist can reduce the amount of power the Ekso is sending to the robotic legs if the user’s muscles are capable of doing some of the work. And, in a crucial feature for stroke rehab, the therapist can also set different power levels for each leg. That feature is useful for stroke patients who experience paralysis on just one side of their bodies.
The software draws data from dozens of sensors in the Ekso’s frame and motors, which track how much power is being supplied by the robot for each step, and how much (if any) by the user’s muscles. The Ekso displays this info for the therapist, who can use it to adjust levels and push the user to work harder. For patients with incomplete spinal cord injuries, like Oldt, that workout strengthens and repairs neural connections between the brain and the dormant muscles.
Up .50 and now down.20...exactly what I was referring to, when I said you have to be careful on big moves with no news...what news drove it higher? Looks like none...Only momentum, now comes the sell off.
I agree that run ups on high volume shows fundamental interest in a stock but there is always some type of news somewhere that is causing people to become interested. We haven't seen anything of product releases or sales. (today's news of Smart Assist software) I believe big investors are getting better insight into EKSO progress than we are. Whatever the reason, I am glad it's paying off for all of us.
My original buy was 1.10 pre-reverse split so that = 7.70. but I was able to dollar cost avg. down to 5.50 with 3 more purchases of the same amount of share each time. Would have been nice the get 1 more buy at 3.60 but I just wasn't feeling good about they way things were. Have to be careful with this running with no news. I really have no idea what is causing the run and have no idea what to do. I guess I'll just settle for what I have.
I was out working as well. Nice to come home to. I will hold off on the "taking off" part until I am above break even. I need 5.50...some good news released would really get us moving.
Don't know if you have seen this, 30 August '16...Behind the Bell...
Tom Looby, Russ Angold and Kevin Oldt...about the 5:40 mark Tom talks about what is being worked on for the future.
https://www.facebook.com/NASDAQ/videos/vb.13881287428/10154391814237429/?type=2&theater